SDEF experts tackle atopic dermatitis

 

Atopic dermatitis (AD) is among the nuts and bolts of any dermatology practice, and as such, gets its time in the spotlight at SDEF’s Annual Hawaii Dermatology Seminar.

This year, SDEF celebrates 41 years of educating dermatologists with the latest in dermatology, featuring presentations from experts on topics ranging from AD treatments and skin cancer chemoprevention to botulinum toxin injections and fillers.

At the 2017 meeting, Lawrence Eichenfield, MD, professor of dermatology and pediatrics at the University of California, San Diego, is scheduled to moderate the clinical update on pediatric dermatology session and will also present updates on AD and acne. At last year’s meeting, Dr. Eichenfield discussed the rapidly expanding list of comorbidities associated with AD, featured in this story.

Also last year, Joseph F. Fowler Jr., MD, meeting codirector and clinical professor of dermatology at the University of Louisville (Ky.), shared in a video interview his perspective on addressing parents’ safety concerns about the boxed warning for topical calcineurin inhibitors.

Watch for more coverage and comments from experts at this year’s meeting.



SDEF and this news organization are owned by the same parent company.
 

dermnews@frontlinemedcom.com

 

Atopic dermatitis (AD) is among the nuts and bolts of any dermatology practice, and as such, gets its time in the spotlight at SDEF’s Annual Hawaii Dermatology Seminar.

This year, SDEF celebrates 41 years of educating dermatologists with the latest in dermatology, featuring presentations from experts on topics ranging from AD treatments and skin cancer chemoprevention to botulinum toxin injections and fillers.

At the 2017 meeting, Lawrence Eichenfield, MD, professor of dermatology and pediatrics at the University of California, San Diego, is scheduled to moderate the clinical update on pediatric dermatology session and will also present updates on AD and acne. At last year’s meeting, Dr. Eichenfield discussed the rapidly expanding list of comorbidities associated with AD, featured in this story.

Also last year, Joseph F. Fowler Jr., MD, meeting codirector and clinical professor of dermatology at the University of Louisville (Ky.), shared in a video interview his perspective on addressing parents’ safety concerns about the boxed warning for topical calcineurin inhibitors.

Watch for more coverage and comments from experts at this year’s meeting.



SDEF and this news organization are owned by the same parent company.
 

dermnews@frontlinemedcom.com

 

Atopic dermatitis (AD) is among the nuts and bolts of any dermatology practice, and as such, gets its time in the spotlight at SDEF’s Annual Hawaii Dermatology Seminar.

This year, SDEF celebrates 41 years of educating dermatologists with the latest in dermatology, featuring presentations from experts on topics ranging from AD treatments and skin cancer chemoprevention to botulinum toxin injections and fillers.

At the 2017 meeting, Lawrence Eichenfield, MD, professor of dermatology and pediatrics at the University of California, San Diego, is scheduled to moderate the clinical update on pediatric dermatology session and will also present updates on AD and acne. At last year’s meeting, Dr. Eichenfield discussed the rapidly expanding list of comorbidities associated with AD, featured in this story.

Also last year, Joseph F. Fowler Jr., MD, meeting codirector and clinical professor of dermatology at the University of Louisville (Ky.), shared in a video interview his perspective on addressing parents’ safety concerns about the boxed warning for topical calcineurin inhibitors.

Watch for more coverage and comments from experts at this year’s meeting.



SDEF and this news organization are owned by the same parent company.
 

dermnews@frontlinemedcom.com